CH560198A5 - - Google Patents
Info
- Publication number
- CH560198A5 CH560198A5 CH1858371A CH1858371A CH560198A5 CH 560198 A5 CH560198 A5 CH 560198A5 CH 1858371 A CH1858371 A CH 1858371A CH 1858371 A CH1858371 A CH 1858371A CH 560198 A5 CH560198 A5 CH 560198A5
- Authority
- CH
- Switzerland
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
- C07D239/82—Oxygen atoms with an aryl radical attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11833270A JPS4834598B1 (cg-RX-API-DMAC10.html) | 1970-12-23 | 1970-12-23 | |
| JP46001477A JPS4940476B1 (cg-RX-API-DMAC10.html) | 1971-01-19 | 1971-01-19 | |
| JP3489771 | 1971-05-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH560198A5 true CH560198A5 (cg-RX-API-DMAC10.html) | 1975-03-27 |
Family
ID=27274937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1858371A CH560198A5 (cg-RX-API-DMAC10.html) | 1970-12-23 | 1971-12-20 |
Country Status (11)
| Country | Link |
|---|---|
| AU (1) | AU438472B2 (cg-RX-API-DMAC10.html) |
| BE (1) | BE777102A (cg-RX-API-DMAC10.html) |
| CA (1) | CA981672A (cg-RX-API-DMAC10.html) |
| CH (1) | CH560198A5 (cg-RX-API-DMAC10.html) |
| DD (1) | DD95845A5 (cg-RX-API-DMAC10.html) |
| DE (1) | DE2162327C3 (cg-RX-API-DMAC10.html) |
| DK (1) | DK129996B (cg-RX-API-DMAC10.html) |
| FR (1) | FR2118932A1 (cg-RX-API-DMAC10.html) |
| HU (1) | HU163789B (cg-RX-API-DMAC10.html) |
| NL (1) | NL7117652A (cg-RX-API-DMAC10.html) |
| SE (1) | SE405729B (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4343940A (en) * | 1979-02-13 | 1982-08-10 | Mead Johnson & Company | Anti-tumor quinazoline compounds |
| WO1993004047A1 (en) * | 1991-08-16 | 1993-03-04 | Merck & Co., Inc. | Quinazoline derivatives as inhibitors of hiv reverse transcriptase |
| IL102764A0 (en) * | 1991-08-16 | 1993-01-31 | Merck & Co Inc | Quinazoline derivatives,and pharmaceutical compositions containing them |
| KR100607634B1 (ko) * | 1998-10-16 | 2006-08-02 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 퀴나졸리논 유도체 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH515911A (de) * | 1968-07-01 | 1971-11-30 | Sandoz Ag | Verfahren zur Herstellung von 3,4-Dihydro-4-phenyl-2(1H)-chinazolinonen |
| GB1251600A (cg-RX-API-DMAC10.html) * | 1968-07-18 | 1971-10-27 | ||
| US3712892A (en) * | 1969-08-02 | 1973-01-23 | Sumitomo Chemical Co | Quinazolinone derivatives |
-
1971
- 1971-12-15 DE DE19712162327 patent/DE2162327C3/de not_active Expired
- 1971-12-15 AU AU36921/71A patent/AU438472B2/en not_active Expired
- 1971-12-17 FR FR7145497A patent/FR2118932A1/fr active Granted
- 1971-12-20 CH CH1858371A patent/CH560198A5/xx not_active IP Right Cessation
- 1971-12-21 DK DK626971A patent/DK129996B/da unknown
- 1971-12-21 SE SE1642571A patent/SE405729B/xx unknown
- 1971-12-22 CA CA130,858A patent/CA981672A/en not_active Expired
- 1971-12-22 DD DD15980771A patent/DD95845A5/xx unknown
- 1971-12-22 NL NL7117652A patent/NL7117652A/xx not_active Application Discontinuation
- 1971-12-22 BE BE777102A patent/BE777102A/xx not_active IP Right Cessation
- 1971-12-23 HU HUSU000704 patent/HU163789B/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2162327C3 (de) | 1975-09-18 |
| DK129996C (cg-RX-API-DMAC10.html) | 1975-05-20 |
| DE2162327A1 (de) | 1972-07-13 |
| AU438472B2 (en) | 1973-08-09 |
| DD95845A5 (cg-RX-API-DMAC10.html) | 1973-02-20 |
| CA981672A (en) | 1976-01-13 |
| FR2118932B1 (cg-RX-API-DMAC10.html) | 1975-10-10 |
| FR2118932A1 (en) | 1972-08-04 |
| SE405729B (sv) | 1978-12-27 |
| DK129996B (da) | 1974-12-09 |
| AU3692171A (en) | 1973-06-21 |
| NL7117652A (cg-RX-API-DMAC10.html) | 1972-06-27 |
| DE2162327B2 (de) | 1975-01-30 |
| HU163789B (cg-RX-API-DMAC10.html) | 1973-10-27 |
| BE777102A (fr) | 1972-04-17 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |